Investment ThemesDetailed Quotes
Weight Loss Drugs
Watchlist
GLP-1 weight-loss drug, whose full name is Glucagon-like peptide-1 receptor agonist. Initially, GLP-1 was a hormone secreted by the gastrointestinal tract mainly used for treating diabetes, but it has also been used to suppress appetite and control weight.
- 1514.041
- +13.086+0.87%
Close Jan 2 16:00 ET
1530.493High1506.467Low
1522.432Open1500.954Pre Close46.37MVolume5Rise55.90P/E (Static)3.51BTurnover--Flatline0.44%Turnover Ratio1.43TMarket Cap2Fall1.31TFloat Cap
Constituent Stocks: 7Top Rising: GPCR+3.95%
always respecting the premarket master.
Go Go Go
Atavistik Bio Has Entered Into A Research Collaboration With Pfizer For Precision Allosteric Therapeutics, Leveraging Atavistik Bio's Platform To Identify And Validate Allosteric Binders Against Two Undisclosed, Pfizer-designated Targets, Financial Terms Were Not Disclosed.
Get Related Content Below. Visit my Youtube For Dedicated Watchlists.
Crown Electrokinetics (CRKN): 2025 Stock Split Vote & Price Target.
Canoo (GOEV): 2024 Reverse Split – Revival or Ruin?
CVS Stock Explained and Pharmacy Benefit Managers.
Please Click The Link To Watch From Youtube. You'll Be Supporting the Channel So We Can Continue To Put Out Usefull Inf...
Shortly after close, the $S&P 500 Index (.SPX.US)$ dipped 0.43% to 5,881.63, the $Dow Jones Industrial Average (.DJI.US)$ edged down 0.07% to 42,544.22, and the $Nasdaq Composite Index (.IXIC.US)$ dropped 0.9% to 19,310.79.
For the year, the Nasdaq Composite led the way, rising 29%. The S&P 500 was up 23% (a second straight year of 20% gains) and the Dow added almost 13%.
MACR...
No comment yet